HTB homepage • Conference reports • Articles by subject • Subscribe March 2005 Contents Editorial Volume 6 Number 2/3 February/March 2005 Treatment alerts Important new pharmacokinetic data demonstrating that atazanavir sulfate (Reyataz) combined with ritonavir (Norvir) and proton pump inhibitors should not be coadministered Conference reports 7th International Congress on Drug Therapy in HIV Infection (ICDTHI), 14-18 November 2004, Glasgow Nandrolone decanoate combats HIV-related weight loss: results from three randomised studies Atazanavir boosts intracellular saquinavir levels: data on important new dual-boosted regimen Marked variability in plasma atazanavir levels: importance of ritonavir boosting and TDM Effective switching to atazanavir/ritonavir in clinical practice Ritonavir boosting may not overcome interaction between atazanavir and nevirapine Nevirapine associated adverse events in a cohort of pregnant women Higher nevirapine doses for children leads to better outcome TDM in Ugandan study highlights importance of refridgerated ritonavir Responses to TB treatment in HIV positive and HIV negative patients in the UK 800mg efavirenz may not be needed with rifampicin-based TB regimens, especially in African patients EuroSIDA shows HIV-HCV coinfected patients more likely to stop HAART because of side effects Lower d4T dose maintains virologic suppression and CD4 increases Antiretrovirals Widespread adoption of post exposure prophylaxis (PEP) recommended in US European Approval For Kivexa (abacavir/3TC) 500 mg saquinavir (Invirase) approved in US Indinavir not recommended in pregnancy due to reduced pharmacokinetic levels Treatment access Community advocates meet with Indian generic companies: 2nd World CAB meeting AIDS activists concerned over drug prices post-patent India’s choice: editorial from NY Times Ranbaxy files three generic ARVs with US FDA FDA approves generic AZT/3TC/NVP fixed dose combination Treatment Access Campaign (TAC) awarded punitive costs in case against Minister of Health GSK grants license to Cipla in South Africa PK and drug interactions Interactions between African herbal medicines and ARVs Other news Free illustrated HIV guide for GPs and other primary care workers ARV drug recycling project in UK First pharmacogenomic CYP450 test designed for clinic use On the web Role of HIV drug resistance testing in antiretroviral drug development Medscape full-text articles and guidelines PDFs Volume 6 Number 2/3 February/March 2005 PDF HTB homepage • Conference reports • Articles by subject • Subscribe
